Fisher Asset Management
OTLK icon

Fisher Asset Management’s Outlook Therapeutics OTLK Stock Holding History

Fisher Asset Management’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-624
Closed -$13.6K – 1198
2023
Q1 		$13.6K Buy
+624
New +$14K ﹤0.01% 1043

Other funds holding OTLK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LA
LVW Advisors Pittsford, New York $1.16B AUM 26.37% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
LNC
Lincoln National Corp Radnor, Pennsylvania $3.91B AUM 14.77% 1-Year Est. Return

Fisher Asset Management's OTLK Position: Q2 2023 in Review

Fisher Asset Management sold out of Outlook Therapeutics (OTLK) in Q2 2023, closing a stake of 624 shares — an estimated $13.6K sold.

Fisher Asset Management first reported a position in OTLK in Q1 2023 and held it in 1 quarter. The position peaked at $13.6K in Q1 2023. 87 funds tracked by Wall St. Rank hold OTLK as of Q2 2023.

  • Fisher Asset Management reported no remaining Outlook Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Fisher Asset Management sold 624 Outlook Therapeutics shares in Q2 2023, an estimated $13.6K.
  • Fisher Asset Management first reported a position in Outlook Therapeutics in Q1 2023 and held it in 1 quarter.
  • Fisher Asset Management's Outlook Therapeutics position peaked at $13.6K in Q1 2023.
  • 87 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q2 2023.

Based on Fisher Asset Management's 13F filing for Q2 2023, filed 8 Aug 2023.